Bonciani D., Verdelli A., Bonciolini V. et al. Dermatitis herpetiformis: from the genetics to the development of skin lesions. Clin Dev Immunol. 2012. - 2012, р. 239691;
Salmi T.T., Hervonen K., Kautiainen H. et al. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br J Dermatol. 2011; 165; 354 359.
Форма Федерального статистического наблюдения №12 «Сведения о числе заболеваний, зарегистрированных у пациентов, проживающих в районе обслуживания медицинской организации за 2014 г.».
Herrero-González J.E. Clinical guidelines for the diagnosis and treatment of dermatitis herpetiformis. Actas Dermosifiliogr. 2010; 101 (10): 820 826.
Reunala T., Lokki J. Dermatitis herpetiformis in Finland. Acta Derm Venereol. 1978; 58: 505 510.
Mobacken H., Kastrup W., Nilsson L.A. Incidence and prevalence of dermatitis herpetiformis in western Sweden. Acta Derm Venereol. 1984; 64; 400 404.
Christensen O.B., Hindsén M., Svensson A. Natural history of dermatitis herpetiformis in southern Sweden. Dermatologica. 1986; 173: 271 277.
Burrows D. The prevalence of dermatitis herpetiformis. Br J Dermatol. 1972; 86: 437.
Buckley D.B., English J., Molloy W. et al. Dermatitis herpetiformis: a review of 119 cases. Clin Exp Dermatol. 1983; 8: 477 487.
Gawkrodger D.J., Blackwell J.N., Gilmour H.M. et al. Dermatitis herpetiformis: diagnosis, diet and demography. Gut. 1984; 25: 151 157.
Moi H. Incidence and prevalence of dermatitis herpetiformis in a country in central Sweden, with comments on the course of the disease and IgA deposits as diagnostic criterion. Acta Derm Venereol. 1984; 64: 144 150.
Самцов А.А., Белоусова И.Э. Буллезные дерматозы. Монография / Спб: ООО «Издательско-полиграфическая компания «КОСТА», 2012. 144 с.
Кубанов А.А., Знаменская Л.Ф., Абрамова Т.В. Дифференциальная диагностика пузырных дерматозов. Вестник дерматологии и венерологии 2016; (6): 43 56.
Альбанова В.И., Нефедова М.А. Аутоиммунные буллезные дерматозы. Дифференциальный диагноз. Вестник дерматологии и венерологии 2017; (3): 10 20.
Белецкая Л.В., Махнева Н.В. Меченые антитела в нормальной и патологической морфологии (атлас). Москва: МНПИ, 2000, 111 с.
Caproni M., Antiga E., Melani L. et al. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2009; 23 (6) 633 638.
Antigo E., Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosm Investig Dermatol. 2015; 8: 257 265.
Bolotin D., Petronic-Rosic V. Dermatitis herpetiformis. Part II: diagnosis, management and prognosis. J Am Acad Dermatol. 2011; 64: 1027 1034.
Dieterich W., Laag E., Bruckner-Tuderman L. et al. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol. 1999; 113: 133 136
Koop I., Ilchmann R., Izzi L. et al. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol. 2000; 95: 2009 2014.
Wolverton S.E. Monitoring for adverse effects from systemic drugs used in dermatology. J Am Acad Dermatol. 1992; 26 (5 Pt 1): 661 679.
Wolverton S.E., Remlinger K. Suggested guidelines for patient monitoring: hepatic and hematologic toxicity attributable to systemic dermatologic drugs. Dermatol Clin. 2007; 25 (2): 195 205.
Tangamornsuksan W., Lohitnavy M. Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions: a systematic review and meta-analysis. JAMA Dermatol. 2018; 154 (4): 441 446.
Linares, V., Alonso, V., Domingo J.L. Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity. Expert Opin Drug Saf. 2011; 10 (2): 253 263.
Bardella M.T., Fredella C., Trovato C. et al. Long-term remission in patients with dermatitis herpetiformis on a normal diet. Br J Dermatol. 2003; 149 (5): 968 971.
Cardones A.R., Hall R.P. Management of dermatitis herpetiformis. Immunol Allergy Clin N Am 2012; 32: 275 281